Sinus Node Disease: DANPACE II trial: Study Debunks Pacing Myth: Minimizing Pacing Doesn't Curb A-Fib

https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/82/43/b7/8243b73b-2d11-1311-21be-68683a295068/mza_12804423687283069731.jpg/600x600bb.jpg

'Why we do What we do in Cardiology'

Bishnu Subedi

35 episodes

5 days ago

I am Dr. Bishnu Subedi. I am a cardiologist in the United States. In the era of evidence-based medicine, our practice is usually guided by a scientific study, expert society statements, or clinical guidelines. In this podcast series, I intend to highlight some of these practice-changing articles in the field of cardiology from past and present.

Medicine

Health & Fitness

RSS

All content for 'Why we do What we do in Cardiology' is the property of Bishnu Subedi and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/5443800/5443800-1710051687903-3d02caa2ebc39.jpg

Sinus Node Disease: DANPACE II trial: Study Debunks Pacing Myth: Minimizing Pacing Doesn't Curb A-Fib

'Why we do What we do in Cardiology'

3 minutes 56 seconds

1 year ago

Sinus Node Disease: DANPACE II trial: Study Debunks Pacing Myth: Minimizing Pacing Doesn't Curb A-Fib

Key points of the DANPACE II study on atrial pacing and atrial fibrillation in sinus node dysfunction:

1. Minimizing atrial pacing in pacemakers doesn't prevent atrial fibrillation (AF):

• 46% of patients regardless of pacing rate (40bpm or 60bpm) experienced an AF episode lasting over 6 minutes during 2 years.

• No difference in AF rates across age, heart rhythm patterns, or prior AF history.

2. Safety concerns: Lower pacing rate linked to increased presyncope/syncope (22% vs 13%).

• Some patients initially assigned to 40bpm required device reprogramming to a higher rate due to these issues.

3. Standard pacing settings (60bpm with rate-adaptive pacing) are recommended unless individual needs require adjustment.

• Rate-adaptive pacing adjusts to activity level, providing adequate heart rate while minimizing unnecessary atrial pacing.

4. Optimal pacing rate remains under investigation for further minimizing AF and syncope.

• Future studies are needed to identify specific patient groups who might benefit from atrial pacing minimization.

5. Overall, DANPACE II clarifies pacemaker programming strategies for sinus node dysfunction patients.

• While minimizing atrial pacing isn't generally effective for preventing AF, the study provides valuable insights for optimizing pacemaker settings to ensure patient safety and well-being.

Link to article: https://doi.org/10.1093/eurheartj/ehad564